脂质体两性霉素B治疗意大利内脏利什曼病婴儿的疗效和耐受性 - Suppr | 超能文献

Efficacy and tolerability of liposomal amphotericin B in Italian infants with visceral leishmaniasis.

作者信息

di Martino L, Raimondi F, Scotti S, Davidson R N, Gradoni L, Giacchino R

机构信息

Dipartimento di Pediatria, Università di Napoli, Italy.

出版信息

Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):477. doi: 10.1016/0035-9203(93)90045-r.

DOI:10.1016/0035-9203(93)90045-r

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Efficacy and tolerability of liposomal amphotericin B in Italian infants with visceral leishmaniasis.脂质体两性霉素B治疗意大利内脏利什曼病婴儿的疗效和耐受性

Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):477. doi: 10.1016/0035-9203(93)90045-r.

2

Liposomal amphotericin B in drug-resistant visceral leishmaniasis.脂质体两性霉素B治疗耐药性内脏利什曼病。

Lancet. 1991 May 4;337(8749):1061-2. doi: 10.1016/0140-6736(91)91708-3.

3

Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.脂质体两性霉素B。在真菌感染和内脏利什曼病治疗中的应用。

Drugs. 1998 Apr;55(4):585-612. doi: 10.2165/00003495-199855040-00008.

4

U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.美国食品药品监督管理局批准安必素（两性霉素B脂质体）用于治疗内脏利什曼病。

Clin Infect Dis. 1999 Jan;28(1):49-51. doi: 10.1086/515086.

5

Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus.脂质体两性霉素B治疗合并人类免疫缺陷病毒感染患者内脏利什曼病的疗效

Clin Infect Dis. 1995 Jan;20(1):191. doi: 10.1093/clinids/20.1.191.

6

Liposomal amphotericin B for the treatment of visceral leishmaniasis.脂质体两性霉素B用于治疗内脏利什曼病。

Clin Infect Dis. 2006 Oct 1;43(7):917-24. doi: 10.1086/507530. Epub 2006 Aug 28.

7

Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus.间歇性脂质体两性霉素B治疗人类免疫缺陷病毒感染患者内脏利什曼病的疗效

Clin Infect Dis. 1995 Sep;21(3):711-2. doi: 10.1093/clinids/21.3.711.

8

Successful treatment of resistant visceral leishmaniasis with liposomal amphotericin B.脂质体两性霉素B成功治疗耐药性内脏利什曼病

Trans R Soc Trop Med Hyg. 1994 Mar-Apr;88(2):228. doi: 10.1016/0035-9203(94)90309-3.

9

Early efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis.脂质体两性霉素B治疗内脏利什曼病的早期疗效

Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):317-8. doi: 10.1016/s0035-9203(96)90270-9.

10

Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases.脂质体两性霉素B治疗和二级预防HIV感染患者内脏利什曼病的疗效：两例报告

J Antimicrob Chemother. 1993 Oct;32(4):657-9. doi: 10.1093/jac/32.4.657.

引用本文的文献

1

Treatment of Mediterranean visceral leishmaniasis.地中海内脏利什曼病的治疗

Bull World Health Organ. 1995;73(2):191-7.